Business · 23/04/2025Updated: 10/17/2026 · 1 min read
FDA Approves EYLEA HD (aflibercept) Product Under Priority Review Voucher
Summary
The FDA has approved EYLEA HD (aflibercept), a material threat medical countermeasure, under a priority review voucher, following its August 18, 2023 approval.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →